|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,169,916 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-07-03 |
4 |
AS |
$23.84 |
$119,185 |
D/D |
(5,000) |
19,822 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2006-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
23,490 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2006-07-03 |
4 |
D |
$24.26 |
$43,644 |
D/D |
(1,799) |
16,990 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2006-07-03 |
4 |
OE |
$20.45 |
$40,616 |
D/D |
1,986 |
18,789 |
|
- |
|
Kremer Alton B |
VP, Clinical Research |
|
2006-06-21 |
4 |
AS |
$21.60 |
$18,900 |
D/D |
(875) |
6,187 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-06-21 |
4 |
AS |
$21.62 |
$270,263 |
D/D |
(12,500) |
592,329 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-06-21 |
4 |
AS |
$21.60 |
$19,440 |
D/D |
(900) |
19,822 |
|
- |
|
Boyd Thomas A |
Sr. VP, Product Dev. |
|
2006-06-21 |
4 |
AS |
$21.64 |
$81,139 |
D/D |
(3,750) |
16,755 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-06-20 |
4 |
AS |
$21.62 |
$21,620 |
D/D |
(1,000) |
17,203 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2006-06-20 |
4 |
AS |
$21.41 |
$64,239 |
D/D |
(3,000) |
14,244 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-06-15 |
4 |
AS |
$22.00 |
$215,054 |
D/D |
(9,774) |
604,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-06-15 |
4 |
OE |
$5.33 |
$52,095 |
D/D |
9,774 |
608,603 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-06-01 |
4 |
AS |
$21.84 |
$109,220 |
D/D |
(5,000) |
20,722 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-06-01 |
4 |
OE |
$4.00 |
$20,000 |
D/D |
5,000 |
25,722 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-06-01 |
4 |
AS |
$21.79 |
$218,152 |
D/D |
(10,000) |
604,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-06-01 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
607,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-05-15 |
4 |
AS |
$20.91 |
$209,090 |
D/D |
(10,000) |
604,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-05-15 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
614,829 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-05-05 |
4 |
AS |
$24.00 |
$93,432 |
D/D |
(3,893) |
18,203 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-05-05 |
4 |
OE |
$4.00 |
$15,572 |
D/D |
3,893 |
22,096 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-05-04 |
4 |
AS |
$24.00 |
$242,568 |
D/D |
(10,107) |
18,203 |
|
- |
|
Olson William C |
VP, Research & Development |
|
2006-05-04 |
4 |
OE |
$4.00 |
$40,428 |
D/D |
10,107 |
28,310 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-05-01 |
4 |
AS |
$23.52 |
$235,200 |
D/D |
(10,000) |
604,829 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2006-05-01 |
4 |
OE |
$5.33 |
$53,300 |
D/D |
10,000 |
614,829 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2006-05-01 |
4 |
AS |
$23.51 |
$117,550 |
D/D |
(5,000) |
20,722 |
|
- |
|
801 Records found
|
|
Page 23 of 33 |
|
|